Marina Biotech Granted Patent Rights in China for Intranasal Insulin Delivery Formulations

Marina Biotech Granted Patent Rights in China for Intranasal Insulin Delivery Formulations
BOTHELL, WA– – Marina Biotech, Inc. , a leading oligonucleotide-based drug discovery and development company, reported that the State Intellectual Property Office of the People’s Republic of China has …